Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22 USD | -0.86% | +4.66% | -14.54% |
Sales 2024 * | 1.88B 176M | Sales 2025 * | 3.16B 297M | Capitalization | 6.31B 593M |
---|---|---|---|---|---|
Net income 2024 * | 85M 7.98M | Net income 2025 * | 1.09B 103M | EV / Sales 2024 * | 3.29 x |
Net cash position 2024 * | 125M 11.77M | Net cash position 2025 * | 1.21B 113M | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
27.8
x | P/E ratio 2025 * |
5.1
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.29% |
Latest transcript on Calliditas Therapeutics AB
1 day | -0.86% | ||
1 week | +4.66% | ||
Current month | +10.33% | ||
1 month | +17.65% | ||
3 months | +5.16% | ||
6 months | +30.80% | ||
Current year | -14.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 17-05-17 | |
Director of Finance/CFO | 47 | 17-07-31 | |
Chief Tech/Sci/R&D Officer | 60 | 20-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 23-05-29 |
Henrik Stenqvist
BRD | Director/Board Member | 57 | 21-12-31 |
Elmar Schnee
CHM | Chairman | 65 | 19-05-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 22 | -0.86% | 5,288 |
24-05-17 | 22.19 | +0.73% | 754 |
24-05-16 | 22.03 | -0.48% | 954 |
24-05-15 | 22.14 | -2.01% | 1,653 |
24-05-14 | 22.59 | +7.47% | 6,700 |
Delayed Quote Nasdaq, May 20, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.78% | 78.65B | |
+9.32% | 8.94B | |
-10.76% | 5.16B | |
+54.31% | 4.85B | |
+11.19% | 4.19B | |
-22.37% | 2.32B | |
+10.97% | 2.29B | |
-30.09% | 2.19B | |
+20.63% | 2.19B |
- Stock Market
- Equities
- CALTX Stock
- CALT Stock